Abstract
Recent publications on early results of the Dutch trial on pre‐operative radiotherapy combined with total mesorectal excision (TME) for resectable rectal cancer have initiated a major swing towards routine radiotherapy of this type. However, detailed analysis of the data so far published shows 23.3% microscopic margin involvement and 23.9% macroscopically poor specimens in a sample group. Since only mobile tumours were selected these figures are too high to validate the claim that the whole series represents ‘standardized TME surgery’. The role of pre‐operative radiotherapy for resectable rectal cancer undergoing optimal surgery therefore remains open. It may be expected that in future the individual indication for pre‐operative radiotherapy will be based on the findings of pre‐operative modern fine slice high resolution magnetic resonance imaging (MRI).